Patents by Inventor Futoshi SHIKATA

Futoshi SHIKATA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TABLET, MEDICINE, METHODS FOR PRODUCING THESE, AND KIT
    Publication number: 20230105591
    Abstract: An object of the present invention is to provide a tablet with excellent permeability and retention ability of active pharmaceutical ingredients. This object can be achieved with a tablet for being impregnated with an active pharmaceutical ingredient, with the tablet comprising a monosaccharide and/or disaccharide.
    Type: Application
    Filed: March 29, 2021
    Publication date: April 6, 2023
    Inventors: Shusuke Sano, Shuntaro Arase, Futoshi Shikata
  • DRUG SUBSTANCE OF LEMBOREXANT AND MEDICINAL COMPOSITION COMPRISING SAME
    Publication number: 20230103250
    Abstract: There is provided a pharmaceutical composition comprising lemborexant exhibiting a favorable dissolution profile by using a granular material having a 90% cumulative diameter (D90) of 64 ?m or less as a lemborexant active pharmaceutical ingredient.
    Type: Application
    Filed: January 14, 2021
    Publication date: March 30, 2023
    Inventors: Taichi ABE, Yusuke AYATA, Nobuya SUZUKI, Yurie AKIMOTO, Futoshi SHIKATA, Yasuhiro Zaima, Nobuo YOSHIDA
  • METHOD FOR TREATING CANCER
    Publication number: 20210060030
    Abstract: The present invention relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
    Type: Application
    Filed: August 20, 2020
    Publication date: March 4, 2021
    Inventors: Heike KEILHACK, Brett TRUITT, Yuta SUZUKI, Tsukasa MURASE, Futoshi SHIKATA
  • Method for treating cancer
    Patent number: 10786511
    Abstract: The present invention relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: September 29, 2020
    Assignees: Epizyme, Inc., Eisai R&D Management Co., Ltd.
    Inventors: Heike Keilhack, Brett Truitt, Yuta Suzuki, Tsukasa Murase, Futoshi Shikata
  • METHOD FOR TREATING CANCER
    Publication number: 20170360797
    Abstract: The present invention relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
    Type: Application
    Filed: November 17, 2015
    Publication date: December 21, 2017
    Inventors: Heike KEILHACK, Brett TRUITT, Yuta SUZUKI, Tsukasa MURASE, Futoshi SHIKATA